Grunenthal GmbH v. Teva Pharm. USA, Inc.
137 S. Ct. 476, 196 L. Ed. 2d 385, 85 U.S.L.W. 3237, 2016 WL 4679697, 2016 U.S. LEXIS 6872
This text of 137 S. Ct. 476 (Grunenthal GmbH v. Teva Pharm. USA, Inc.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Grunenthal GmbH v. Teva Pharm. USA, Inc., 137 S. Ct. 476, 196 L. Ed. 2d 385, 85 U.S.L.W. 3237, 2016 WL 4679697, 2016 U.S. LEXIS 6872 (U.S. 2016).
Opinion
Petitions for writs of certiorari to the United States Court of Appeals for the Federal Circuit denied.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
Bluebook (online)
137 S. Ct. 476, 196 L. Ed. 2d 385, 85 U.S.L.W. 3237, 2016 WL 4679697, 2016 U.S. LEXIS 6872, Counsel Stack Legal Research, https://law.counselstack.com/opinion/grunenthal-gmbh-v-teva-pharm-usa-inc-scotus-2016.